Votre parcours vers l’agilité métier
Here is an uncomfortable reality in all but the smallest firms during their R&D portfolio management processes: Between the staff running each R&D initiative and the executives making project and portfolio decisions, there’s usually a division. Maybe it’s the gap between headquarters and lab, upstairs/downstairs, east coast/west coast, London/Singapore, or even a generation gap. At...
As we start the fourth quarter, having just come back from the annual Association for Financial Professionals (AFP) national conference, it seems like an appropriate time to reflect on the trends of the last year. Read on for seven financial planning and analysis trends from 2012. Trend #1: The Rise of FP&A Within the finance...
Selon les mots de l'une des plus brillantes étoiles du baseball, Yogi Berra, "Si vous ne savez pas où vous allez, vous pourriez vous retrouver ailleurs". Obtenez une victoire pour votre projet informatique et réalisez plus de revenus en mettant en œuvre ces conseils clés de gestion de projet. Livrer les projets à temps et dans le respect du budget. Mettez juste votre manager...
I recently attended the Optimizing Innovation Conference in NYC as Planview was a sponsor. Initially, I was surprised that half of the attendees had traveled from Europe just for a two-day conference. Once the sessions began, I quickly understood their motivation. Speakers from Levi® Strauss, NASA, MTV Networks, Goodyear®, Mozilla, Kraft, and many other companies...
Dan Smith and I have written a white paper on strategic R&D portfolio management that summarizes many of the lessons and insights we’ve gleaned during twelve years of client engagements. The white paper is organized into eight ‘rules’: Avoid incomplete strategies Build an actionable strategy Don’t buy in to bubble plots Move beyond prioritization Present...
The Product Portfolio Mavens are back and this time they’ve recorded in an undisclosed location. In addition to sharing insights on hitting launch windows and pipeline visibility, Pamela and Carrie provide an update on the PDMA PIM Conference and shed light on the latest product portfolio management rumors.
It’s no secret that projects in the earlier stages of the development lifecycle are evaluated and managed very differently than projects in the later stages. One major pharmaceutical company believed these differences to be so great, however, that they split their development organization in two. Over time, the structural gulf became a cultural gulf, leading...
Par Samir Mukadam, vice-président de la gestion des produits chez Innotas Nous avons brièvement mentionné la gestion du portefeuille d'applications (APM) dans notre dernier billet. Depuis lors, nous avons reçu de nombreux courriels de clients et de prospects sur la façon dont il faut procéder pour déployer l'APM dans leur organisation. -Voici comment Innotas pense qu'une organisation informatique devrait aborder l'APM :...
Humans have always been and will always be storytellers. From the fireside tales of bygone millennia to today’s TV dramas and movies, the power of the narrative holds us in rapt attention as it both entertains and makes sense of the world around us. How does this relate to pharmaceutical portfolio management? Essentially, portfolio management...
Dans la première partie de cette série, intitulée "Comment utiliser la budgétisation annuelle pour augmenter le rendement total pour les actionnaires", j'ai expliqué comment la plupart des entreprises apportent des modifications mineures à leurs allocations budgétaires d'une année sur l'autre. J'ai également fait référence à une étude récente de McKinsey Quarterly qui a révélé qu'au fil du temps, les entreprises ont obtenu en moyenne 30% de rendement total annuel supérieur pour les actionnaires en...
